CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke

Xuefang Ren1, Kozaburo Akiyoshi, Arthur A Vandenbark

  • 1Neuroimmunology Research, R&D-31, Portland Veterans Affairs Medical Center, 3710 SW US Veterans Hospital Rd., Portland, OR 97239, USA.

Metabolic Brain Disease
|November 18, 2010
PubMed
Summary

Regulatory T-cells (Treg) do not limit brain damage after experimental ischemic stroke. Depleting these immune cells in mice did not alter stroke infarct volume, challenging previous findings.